Detalhe da pesquisa
1.
Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.
Value Health
; 23(7): 831-841, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762984
2.
Recommendations for benefit-risk assessment methodologies and visual representations.
Pharmacoepidemiol Drug Saf
; 25(3): 251-62, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800458
3.
A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment.
Biom J
; 58(1): 8-27, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25619173
4.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Pharmacoepidemiol Drug Saf
; 23(7): 667-78, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821575
5.
Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.
Pharmacoepidemiol Drug Saf
; 23(9): 974-83, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043919
6.
Quantifying Preferences in Drug Benefit-Risk Decisions.
Clin Pharmacol Ther
; 106(5): 955-959, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929257